A novel tricolor, dual-fusion fluorescence in situ hybridization method to detect BCR/ABL fusion in cells with t(9;22)(q34;q11.2) associated with deletion of DNA on the derivative chromosome 9 in chronic myelocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 148, Issue 1, 2004, Pages 1-6

  Smoley, Stephanie A ^a   Brockman, Stephanie R ^a   Paternoster, Sarah F ^a   Meyer, Reid G ^a   Dewald, Gordon W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININOSUCCINATE SYNTHASE; BCR ABL PROTEIN; DNA;

ACCURACY; ARTICLE; CANCER DIAGNOSIS; CELL NUCLEUS; CHROMOSOME 9; CHRONIC MYELOID LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTERPHASE; LEUKEMIA CELL; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; TRICOLOR DUAL FUSION FLUORESCENCE IN SITU HYBRIDIZATION; TUMOR CELL;

EQUUS ASINUS;

EID: 0346250817     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00202-4     Document Type: Article

References (10)

1. Dewald G. Interphase fish studies of chronic myeloid leukemia. Fan Y.S. Molecular cytogenetics: protocols and applications. Methods in Molecular Biology. Volume 204:2002;311-342 Humana Press, Totowa, NJ.
2. Dewald G.W., Wyatt W.A., Juneau A.L., Carlson R.O., Zinsmeister A.R., Jalal S.M., Spurbeck J.L., Silver R.T. Highly sensitive fluorescence in situ hybridization method to detect double bcr/abl fusion and monitor response to therapy in chronic myeloid leukemia. Blood. 91:1998;3357-3365.
3. Dewald G.W., Wyatt W.A., Silver R.T. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy. Leuk Lymphoma. 34:1999;481-491.
4. Sinclair P.B., Nacheva E.P., Leversha M., Telford N., Chang J., Reid A., Bench A., Champion K., Huntly B., Green A.R. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood. 95:2000;738-743.
5. Dewald G., Stallard R., Alsaadi A., Arnold S., Blough R., Ceperich T.M., Rafael Elejalde B., Fink J., Higgins J.V., Higgins R.R., Hoeltge G.A., Hsu W.T., Johnson E.B., Kronberger D., McCorquodale D.J., Meisner L.F., Micale M.A., Oseth L., Payne J.S., Schwartz S., Sheldon S., Sophian A., Storto P., Van Tuinen P., Zenger-Hain J. A multicenter investigation with D-FISH BCR/ABL1 probes. Cancer Genet Cytogenet. 116:2000;97-104.
6. Buno I., Wyatt W.A., Zinsmeister A.R., Dietz-Band J., Silver R.T., Dewald G.W. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Blood. 92:1998;2315-2321.
7. Le Gouill S., Talmant P., Milpied N., Daviet A., Ancelot M., Moreau P., Harousseau J.L., Bataille R., Avet-Loiseau H. Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia. J Clin Oncol. 18:2000;1533-1538.
8. Cuneo A., Bigoni R., Emmanuel B., Smit E., Rigolin G.M., Roberti M.G., Bardi A., Piva N., Scapoli G., Castoldi G., Van Den Berghe H., Hagemeijer A. Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: comparison with metaphase banding analysis. Leukemia. 12:1998;1718-1723.
9. Nolte M., Werner M., Ewig M., von Wasielewski R., Wilkens L., Link H., Ganser A., Georgii A. Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for detection of the 9;22 translocation. Leuk Lymphoma. 22:1996;287-294.
10. Sinclair P.B., Green A.R., Grace C., Nacheva E.P. Improved sensitivity of BCR-ABL detection: a triple-probe three-color fluorescence in situ hybridization system. Blood. 90:1997;1395-1402.